News
1monon MSN
If you find yourself feeling sleepy in the daytime it could be related to a sleep disorder called hypersomnia. So, what is ...
17d
Clinical Trials Arena on MSNAlkermes begins Phase II trial of drug candidate for idiopathic hypersomniaAlkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic ...
If so, it might not just be regular fatigue, it could be Idiopathic Hypersomnia (IH). This neurological sleep disorder causes overwhelming daytime drowsiness, making it difficult to stay awake and ...
There are many different types of sleep disorders, which can lead to additional symptoms and issues like increased depression and anxiety, difficulty focusing and even diabetes or heart disease. Below ...
Think sleeping more is always good for you? Discover how oversleeping can lead to heart disease, diabetes, and even cognitive ...
Melbourne, Australia, April 16, 2025 (GLOBE NEWSWIRE) -- iNGENū CRO, a specialist Contract Research Organization with deep expertise in the ...
in adults with idiopathic hypersomnia (“IH”), a rare, chronic and neurological sleep disorder. The double-blind, placebo-controlled study will evaluate the safety and efficacy of ALKS 2680 ...
Irish biopharmaceutical company Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic hypersomnia (IH). The double-blind ...
17d
Zacks.com on MSNAlkermes Begins Idiopathic Hypersomnia Study on ALKS 2680ALKS' phase II Vibrance-3 study investigates the safety and efficacy of ALKS 2680 versus placebo for treating adults with idiopathic hypersomnia.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results